SCHEMBL7342175

SCHEMBL7342175

CCOC(=O)C(C(=O)OCC)c1cc([N+](=O)[O-])ccc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.50
TP53 P04637 1/20 0.49
HTT P42858 1/20 0.49
ALDH1A1 P00352 5/20 0.49
TDP1 Q9NUW8 3/20 0.49
CYP3A4 P08684 1/20 0.49
ALOX15 P16050 1/20 0.49
MAPT P10636 7/20 0.46
MAPK1 P28482 2/20 0.45
POLB P06746 1/20 0.45
KMT2A Q03164 1/20 0.45
AKR1B1 P15121 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
NPC1 O15118 2/20 0.43
NPBWR1 P48145 1/20 0.43
RAB9A P51151 1/20 0.43
MCHR1 Q99705 1/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6968035 0.95 SMN1; SMN2 (0.48) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL20558473 0.89 TP53 (0.52) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL29529192 0.89 ALDH1A1 (0.51) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL2616867 0.89 ALDH1A1 (0.51) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL19695886 0.88 SMN1; SMN2 (0.49) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL17742882 0.85 ALDH1A1 (0.54) SMN1; SMN2ALDH1A1TDP1CYP3A4MAPT
SCHEMBL9080764 0.83 TP53 (0.49) SMN1; SMN2TP53HTTALDH1A1TDP1
SCHEMBL3340975 0.82 NPSR1 (0.52) SMN1; SMN2ALDH1A1TDP1MAPTMAPK1
SCHEMBL1625485 0.82 ALDH1A1 (0.51) SMN1; SMN2ALDH1A1TDP1CYP3A4MAPT
SCHEMBL4095909 0.81 ALDH1A1 (0.58) SMN1; SMN2TP53HTTALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3562806-A1 METHODS FOR THE PREPARATION OF 6-AMINOISOQUINOLINE Aerie Pharmaceuticals, Inc. (US) 2019-11-06 EP claimed
WO-2018125548-A1 METHODS FOR THE PREPARATION OF 6-AMINOISOQUINOLINE AERIE PHARMACEUTICALS, INC. (US) 2018-07-05 WO claimed
US-9840468-B1 Methods for the preparation of 6-aminoisoquinoline AERIE PHARMACEUTICALS, INC. (US) 2017-12-12 US claimed
EP-3562806-A1 METHODS FOR THE PREPARATION OF 6-AMINOISOQUINOLINE Aerie Pharmaceuticals, Inc. (US) 2019-11-06 EP disclosed
WO-2018125548-A1 METHODS FOR THE PREPARATION OF 6-AMINOISOQUINOLINE AERIE PHARMACEUTICALS, INC. (US) 2018-07-05 WO disclosed
WO-2018125548-A1 METHODS FOR THE PREPARATION OF 6-AMINOISOQUINOLINE AERIE PHARMACEUTICALS, INC. (US) 2018-07-05 WO disclosed
US-9840468-B1 Methods for the preparation of 6-aminoisoquinoline AERIE PHARMACEUTICALS, INC. (US) 2017-12-12 US disclosed
US-9840468-B1 Methods for the preparation of 6-aminoisoquinoline AERIE PHARMACEUTICALS, INC. (US) 2017-12-12 US disclosed
US-9840468-B1 Methods for the preparation of 6-aminoisoquinoline AERIE PHARMACEUTICALS, INC. (US) 2017-12-12 US disclosed
US-6284796-B1 NAPHTHAMIDINE COMPOUNDS ABBOTT LABORATORIES 2001-09-04 US disclosed